chr1-248039045-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001385855.1(OR2L2):c.778C>T(p.Arg260Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000128 in 1,614,070 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001385855.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR2L2 | NM_001385855.1 | c.778C>T | p.Arg260Cys | missense_variant | 3/3 | ENST00000641771.1 | |
OR2L2 | NM_001004686.3 | c.778C>T | p.Arg260Cys | missense_variant | 2/2 | ||
OR2L13 | NM_001304535.3 | c.-18-60313C>T | intron_variant | ||||
OR2L13 | NM_175911.5 | c.-143-59606C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR2L2 | ENST00000641771.1 | c.778C>T | p.Arg260Cys | missense_variant | 3/3 | NM_001385855.1 | P1 | ||
OR2L2 | ENST00000366479.4 | c.778C>T | p.Arg260Cys | missense_variant | 1/1 | P1 | |||
OR2L2 | ENST00000642011.1 | c.778C>T | p.Arg260Cys | missense_variant | 2/2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152094Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000219 AC: 55AN: 251424Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135874
GnomAD4 exome AF: 0.000118 AC: 172AN: 1461858Hom.: 1 Cov.: 33 AF XY: 0.000122 AC XY: 89AN XY: 727230
GnomAD4 genome AF: 0.000230 AC: 35AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | The c.778C>T (p.R260C) alteration is located in exon 1 (coding exon 1) of the OR2L2 gene. This alteration results from a C to T substitution at nucleotide position 778, causing the arginine (R) at amino acid position 260 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at